DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy

Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical Affairs and Scientific Communications (DIA MASC) forum I attended in March 2025, along with a focus on how we can utilize these tools to achieve impactful, engaging, and scientifically accurate communications that resonate with healthcare providers (HCPs) and patients. Along…...
Read More

Top Stories

Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...
AI in Medical Affairs & Medical Communications

Science, AI, and Human Ingenuity Converge to

Today, we're witnessing an unprecedented convergence of...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Counting on AI: The right time for researchers and pharma

Counting on AI: The Right Time for Researchers and Pharma to Embrace Artificial Intelligence

The right AI–powered tools and techniques can make a significant difference in how research is...
Publication planning training

Publication Planning Training for Regional Medical Affairs Team

How a global pharma company overcame challenges of integration with regional teams in terms of...
EU MedTech Summit 2020

EU MedTech Summit 2020: Highlights and Top 3 Takeaways

How is the MedTech industry gearing up for the EU-MDR? Here are some key takeaways...
A summary of journal articles authored by the Cactus Life Sciences team

Our Journal Publication Showcase

A summary of journal articles authored by the Cactus Life Sciences team...
A fireside chat on how MedTech leaders are called to respond to EU-MDR

Fireside Chat Part 1: How MedTech Leaders Are Called to Respond to EU MDR

A fireside chat on how MedTech leaders are called to respond to EU-MDR...
The battle for evidence-based truth in a war of misinformation

The Battle for Evidence-Based Truth in a War of Misinformation

I was talking to someone I know — let’s call her Joanna — about the...

Learn more ABOUT our company.